Patent classifications
A61L2300/802
MEDICAL IMPLANT SURFACE-MODIFIED WITH FUNCTIONAL POLYPEPTIDE
Provided is a medical implant including: an implant base having a surface made of a silicon material; a linker having one end attached onto the surface of the implant base; and a cytokine bound to another end of the linker. By inducing the secretion of anti-inflammatory cytokines, a capsular contracture, which is one of the complications that may occur after transplantation of the patient's breast implant, may occur less.
COMPOSITIONS AND METHODS FOR ADHESION TO SURFACES
Provided herein are compositions and their methods of use to adhere (e.g., in wet and dry environments) a variety of materials together.
DUAL AGENT NANOPARTICLE COMPOSITION FOR COATING MEDICAL DEVICES
A pharmaceutical composition is described. The pharmaceutical composition includes a polymeric coating composition comprising polymeric nanoparticles dispersed within a polymeric matrix, wherein the polymeric nanoparticles include a first therapeutic agent and a second therapeutic agent. Implantable medical devices coated with the pharmaceutical composition, methods of coating an implantable medical device with the pharmaceutical composition, and methods of treating vascular disease using the pharmaceutical composition are also described.
Compositions and Methods for Application Over Skin
Disclosed herein are compositions that can be used to create a thin film on the skin of a subject in a single application step to the skin of the subject. More specifically, a composition provided herein does not have to be stored in multiple compartments, nor mixed with another composition or component before application to the skin. Instead, a single composition can be manufactured, stored in a single compartment, and then applied to the skin of a subject to create a film on the skin of the subject. In certain embodiments, because there is no need to mix a composition provided herein prior to application to the skin, the container comprising a composition provided herein may also include an applicator suitable for application of the composition to the skin.
Hemostatic agent and container containing the same
The present invention relates to a hemostatic composition including collagen, a stabilizer, and thrombin, and a container holding this hemostatic composition. The hemostatic composition and the container holding this hemostatic composition can be applied to an urgent bleeding patient by a simple method of use, and the hemostatic composition is less toxic, does not have a problem of blood infection, has a fast rate of biodegradation, has an excellent hemostatic effect, and can be usefully used as a hemostat.
Effects of heparin on topical use of plasters containing a non-steroidal anti-inflammatory drug
The present invention provides for a method of improving the release of non-steroidal anti-inflammatory drugs (NSAIDs) from a plaster or bandage comprising an adhesive layer with a pharmaceutically acceptable NSAID together with heparin or a heparinoid. The invention also provides for methods of reducing muscle hyperalgesia in subjects without spontaneous pain.
INJECTABLE HOMOGENEOUS GELS COMPRISING MULTIPLE FORMS OF HYALURONIC ACID AND METHODS FOR MANUFACTURING THEREOF
Provided herein are compositions, comprising hyaluronic acid in three different forms. The compositions are in a form of an essentially homogeneous gel with improved rheological properties enabling improved clinical performance.
Expanded nanofiber structures comprising electrospun nanofibers and a plurality of holes and methods of making and use thereof
Expanded, nanofiber structures comprising electrospun nanofibers, a plurality of holes, and, optionally, cells are provided. Methods of making the nanofiber structures as well as methods of use thereof, particularly for wound healing, are also provided.
Infused cartilage particles
A method of making infused non-demineralized cartilage particles employs the following steps: cutting or shaving cartilage tissue into cartilage particles, washing the particles, and infusing the particles with a supernatant of biologic material or a polyampholyte cryoprotectant or a combination of both to create infused particles.
Dental Coating Composition and Method of Use
The dental coating composition of the present invention is suitable to coat dental prosthetics. The composition is a mixture of a (meth)acrylate dimer, a (meth)acrylate crosslinker, a photoinitiator, and a silicone surfactant, and optionally, a (meth)acrylate monomer with a heteroalkyl group, a colorant, special effects pigment, particles, and other additives. Incorporating particles in the dental coating formulation provides a “character” to the surface of the dental prosthetic, increasing the esthetic appeal of the prosthetic. The dental coating thus may make the parts of the dental prosthetic appear to approximate gingivae, or gum. The dental coating composition may be applied to a surface of an unfinished dental prosthesis prior to curing, to a partially cured prosthesis, or fully cured prosthesis.